Search
for
Sort by
Research 301–330 of 311
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- The Comparative Effects Between Long‐Term and Short‐Term Treatment of Finasteride on Anxiety‐Like and Depression‐Like Behaviors in Early Senescent Male Rats
- Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved]
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Symptoms of hypogonadism caused by 5α-reductase inhibitors
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
- Prostate Cancer Early Detection, Version 2.2015
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- The connection of 5-alpha reductase inhibitors to the development of depression
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- 5ARIs and PSA: Evidences
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Effects of 5-alpha reductase inhibitors
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- 5ARI and PSA: open questions
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- The relative effect of monotherapy with 5‐alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta‐analysis study
- FRI-02 FROM GIRLS TO BOYS TO OLDER MEN, THE INTERESTING TALE OF THE GUEVEDOCES AND 5-ALPHA REDUCTASE INHIBITORS